The Asthma and Allergy Foundation of America has released its Asthma Capitals report, which ranks the 100 most populated U.S.

Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...

The FDA has approved AstraZeneca's Fasenra for eosinophilic granulomatosis with polyangiitis based on Phase 3 MANDARA trial ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

The third week of September is known as "peak week" by many asthma and allergy associations because emergency room visits and ...

An asthma attack is much more than just feeling winded after exercise and needing to catch your breath. Learn what can ...

Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... Season of Birth ...

The last week of September is known as Asthma Peak Week. During this time of year, asthma worsens and can cause more issues.

New research shows that infants who were exclusively fed breast milk during their hospitalization right after birth were 22% less likely to develop asthma in early childhood.

Upstream Bio plans to IPO to advance its Phase 2 drug candidate, verekitug, for severe asthma and chronic rhinosinusitis.

The NObreath® measures a person's FeNO level, an important biomarker of lung inflammation, typically associated with asthma.